METTL14 and neoplasm: We next consulted proteomics data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and TCGA-BRCA and found that METTL14 was significantly downregulated in TNBC tissues compared with non-TNBC tissues (Fig. 1e and f).